Literature DB >> 33536622

Ubiquitin ligation to F-box protein targets by SCF-RBR E3-E3 super-assembly.

Daniel Horn-Ghetko1, David T Krist1,2, J Rajan Prabu1, Kheewoong Baek1, Monique P C Mulder3, Maren Klügel1, Daniel C Scott4, Huib Ovaa3, Gary Kleiger5, Brenda A Schulman6,7.   

Abstract

E3 ligases are typically classified by hallmark domains such as RING and RBR, which are thought to specify unique catalytic mechanisms of ubiquitin transfer to recruited substrates1,2. However, rather than functioning individually, many neddylated cullin-RING E3 ligases (CRLs) and RBR-type E3 ligases in the ARIH family-which together account for nearly half of all ubiquitin ligases in humans-form E3-E3 super-assemblies3-7. Here, by studying CRLs in the SKP1-CUL1-F-box (SCF) family, we show how neddylated SCF ligases and ARIH1 (an RBR-type E3 ligase) co-evolved to ubiquitylate diverse substrates presented on various F-box proteins. We developed activity-based chemical probes that enabled cryo-electron microscopy visualization of steps in E3-E3 ubiquitylation, initiating with ubiquitin linked to the E2 enzyme UBE2L3, then transferred to the catalytic cysteine of ARIH1, and culminating in ubiquitin linkage to a substrate bound to the SCF E3 ligase. The E3-E3 mechanism places the ubiquitin-linked active site of ARIH1 adjacent to substrates bound to F-box proteins (for example, substrates with folded structures or limited length) that are incompatible with previously described conventional RING E3-only mechanisms. The versatile E3-E3 super-assembly may therefore underlie widespread ubiquitylation.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33536622      PMCID: PMC7904520          DOI: 10.1038/s41586-021-03197-9

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   69.504


  67 in total

1.  A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p.

Authors:  R M Feldman; C C Correll; K B Kaplan; R J Deshaies
Journal:  Cell       Date:  1997-10-17       Impact factor: 41.582

2.  Systematic analysis and nomenclature of mammalian F-box proteins.

Authors:  Jianping Jin; Timothy Cardozo; Ruth C Lovering; Stephen J Elledge; Michele Pagano; J Wade Harper
Journal:  Genes Dev       Date:  2004-11-01       Impact factor: 11.361

3.  F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex.

Authors:  D Skowyra; K L Craig; M Tyers; S J Elledge; J W Harper
Journal:  Cell       Date:  1997-10-17       Impact factor: 41.582

4.  Two functionally distinct E2/E3 pairs coordinate sequential ubiquitination of a common substrate in Caenorhabditis elegans development.

Authors:  Katja K Dove; Hilary A Kemp; Kristin R Di Bona; Katherine H Reiter; Luke J Milburn; David Camacho; David S Fay; Dana L Miller; Rachel E Klevit
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

Review 5.  RING-type E3 ligases: master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination.

Authors:  Meredith B Metzger; Jonathan N Pruneda; Rachel E Klevit; Allan M Weissman
Journal:  Biochim Biophys Acta       Date:  2013-06-06

6.  An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer.

Authors:  Teresa A Soucy; Peter G Smith; Michael A Milhollen; Allison J Berger; James M Gavin; Sharmila Adhikari; James E Brownell; Kristine E Burke; David P Cardin; Stephen Critchley; Courtney A Cullis; Amanda Doucette; James J Garnsey; Jeffrey L Gaulin; Rachel E Gershman; Anna R Lublinsky; Alice McDonald; Hirotake Mizutani; Usha Narayanan; Edward J Olhava; Stephane Peluso; Mansoureh Rezaei; Michael D Sintchak; Tina Talreja; Michael P Thomas; Tary Traore; Stepan Vyskocil; Gabriel S Weatherhead; Jie Yu; Julie Zhang; Lawrence R Dick; Christopher F Claiborne; Mark Rolfe; Joseph B Bolen; Steven P Langston
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

7.  Robust cullin-RING ligase function is established by a multiplicity of poly-ubiquitylation pathways.

Authors:  Kurt Reichermeier; Daniel C Scott; Lorena Samentar; Jasmin Coulombe-Huntington; Spencer Hill; Luisa Izzi; Xiaojing Tang; Rebeca Ibarra; Thierry Bertomeu; Annie Moradian; Michael J Sweredoski; Nora Caberoy; Brenda A Schulman; Frank Sicheri; Mike Tyers; Gary Kleiger
Journal:  Elife       Date:  2019-12-23       Impact factor: 8.140

8.  UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids.

Authors:  Dawn M Wenzel; Alexei Lissounov; Peter S Brzovic; Rachel E Klevit
Journal:  Nature       Date:  2011-05-01       Impact factor: 49.962

9.  TRIAD1 and HHARI bind to and are activated by distinct neddylated Cullin-RING ligase complexes.

Authors:  Ian R Kelsall; David M Duda; Jennifer L Olszewski; Kay Hofmann; Axel Knebel; Frédéric Langevin; Nicola Wood; Melanie Wightman; Brenda A Schulman; Arno F Alpi
Journal:  EMBO J       Date:  2013-09-27       Impact factor: 11.598

10.  Two Distinct Types of E3 Ligases Work in Unison to Regulate Substrate Ubiquitylation.

Authors:  Daniel C Scott; David Y Rhee; David M Duda; Ian R Kelsall; Jennifer L Olszewski; Joao A Paulo; Annemieke de Jong; Huib Ovaa; Arno F Alpi; J Wade Harper; Brenda A Schulman
Journal:  Cell       Date:  2016-08-25       Impact factor: 41.582

View more
  24 in total

1.  A review on cullin neddylation and strategies to identify its inhibitors for cancer therapy.

Authors:  Iqra Bano; Moolchand Malhi; Min Zhao; Liviu Giurgiulescu; Hira Sajjad; Marek Kieliszek
Journal:  3 Biotech       Date:  2022-03-29       Impact factor: 2.406

2.  Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2.

Authors:  Taylor P Enrico; Wayne Stallaert; Elizaveta T Wick; Peter Ngoi; Xianxi Wang; Seth M Rubin; Nicholas G Brown; Jeremy E Purvis; Michael J Emanuele
Journal:  Elife       Date:  2021-12-01       Impact factor: 8.140

3.  Structural insights into Ubr1-mediated N-degron polyubiquitination.

Authors:  Man Pan; Qingyun Zheng; Tian Wang; Lujun Liang; Junxiong Mao; Chong Zuo; Ruichao Ding; Huasong Ai; Yuan Xie; Dong Si; Yuanyuan Yu; Lei Liu; Minglei Zhao
Journal:  Nature       Date:  2021-11-17       Impact factor: 49.962

Review 4.  A new dawn beyond lysine ubiquitination.

Authors:  Daniel R Squair; Satpal Virdee
Journal:  Nat Chem Biol       Date:  2022-07-27       Impact factor: 16.174

5.  Cullin-independent recognition of HHARI substrates by a dynamic RBR catalytic domain.

Authors:  Katherine H Reiter; Alex Zelter; Maria K Janowska; Michael Riffle; Nicholas Shulman; Brendan X MacLean; Kaipo Tamura; Matthew C Chambers; Michael J MacCoss; Trisha N Davis; Miklos Guttman; Peter S Brzovic; Rachel E Klevit
Journal:  Structure       Date:  2022-06-17       Impact factor: 5.871

6.  Disease-associated KBTBD4 mutations in medulloblastoma elicit neomorphic ubiquitylation activity to promote CoREST degradation.

Authors:  Zhuoyao Chen; Rafael M Ioris; Stacey Richardson; Ava N Van Ess; Iolanda Vendrell; Benedikt M Kessler; Francesca M Buffa; Luca Busino; Steven C Clifford; Alex N Bullock; Vincenzo D'Angiolella
Journal:  Cell Death Differ       Date:  2022-04-04       Impact factor: 12.067

Review 7.  The E3 Ubiquitin Ligase Fbxo4 Functions as a Tumor Suppressor: Its Biological Importance and Therapeutic Perspectives.

Authors:  Shuo Qie
Journal:  Cancers (Basel)       Date:  2022-04-25       Impact factor: 6.575

Review 8.  Decoding the messaging of the ubiquitin system using chemical and protein probes.

Authors:  Lukas T Henneberg; Brenda A Schulman
Journal:  Cell Chem Biol       Date:  2021-04-07       Impact factor: 8.116

Review 9.  Historical perspective and progress on protein ubiquitination at glutamatergic synapses.

Authors:  Angela M Mabb
Journal:  Neuropharmacology       Date:  2021-06-29       Impact factor: 5.273

Review 10.  Cullin-RING Ubiquitin Ligase Regulatory Circuits: A Quarter Century Beyond the F-Box Hypothesis.

Authors:  J Wade Harper; Brenda A Schulman
Journal:  Annu Rev Biochem       Date:  2021-04-06       Impact factor: 27.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.